Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution

Hamid Rizwan, Loyd James

Source: Eur Respir J 2012; 39: 1292-1293
Journal Issue: June
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hamid Rizwan, Loyd James. Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution. Eur Respir J 2012; 39: 1292-1293

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation
Source: Eur Respir J 2012; 39: 1534-1535
Year: 2012


A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Should we screen for hereditary pulmonary hypertension?
Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life
Year: 2020


Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011



Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations
Source: Eur Respir Rev 2013; 22: 515-525
Year: 2013



Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
Source: Eur Respir J 2012; 39: 597-603
Year: 2012



Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001


Novel biomarkers for risk stratification in pulmonary arterial hypertension
Source: ERJ Open Res 2015; 1: 00008-2015
Year: 2015



Pulmonary arterial hypertension: screening challenges in systemic sclerosis and future directions
Source: Eur Respir J, 49 (5) 1700522; 10.1183/13993003.00522-2017
Year: 2017



Novel biomarkers in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Challenges in the diagnosis and treatment of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 313-320
Year: 2012



Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
Year: 2020



The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005

Novel techniques for advancing our understanding of pulmonary arterial hypertension
Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019
Year: 2019



The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009



Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Screening for biomarkers in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012

Novel therapeutic perspectives in pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: 193-194
Year: 2003